Warfarin pharmacogenetics: A controlled dose-response study in healthy subjects

In conclusion, genotype-guided warfarin-dosing algorithms may rely more on genetic variables in healthier individuals than in patients with clinical confounders. ClinicalTrials.gov Identifier: NCT01520402

Source: Vascular Medicine recent issues - October 28, 2013 Category: Internal Medicine Authors: Kadian-Dodov, D. L., van der Zee, S. A., Scott, S. A., Peter, I., Martis, S., Doheny, D. O., Rothlauf, E. B., Lubitz, S. A., Desnick, R. J., Halperin, J. L. Tags: Original Articles Source Type: research